Agile Therapeutics Inc.
08/27/2024 | Press release | Distributed by Public on 08/28/2024 04:03
Notice of Effectiveness - Form EFFECT
Notice of Effectiveness
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 27, 2024 |
| Accession Number: | 0001104659-24-092921 | |||||
| Submission Type: | POS AM | |||||
|